Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elliot DiMilo"'
Autor:
Oscar Vivas, Eamonn J. Dickson, Elliot DiMilo, Leggy A. Arnold, Abdulmohsen Alsafran, Chris Dockendorff, C. David Weaver, Jacob D. Porter
Publikováno v:
Bioorg Med Chem Lett
Bioorganic & medicinal chemistry letters, vol 29, iss 23
Bioorganic & medicinal chemistry letters, vol 29, iss 23
A set of novel Kv7.2/7.3 (KCNQ2/3) channel blockers was synthesized to address several liabilities of the known compounds XE991 (metabolic instability and CYP inhibition) and the clinical compound DMP 543 (acid instability, insolubility, and lipophil
Autor:
Saravanan Subramaniam, Chris Dockendorff, Hartmut Weiler, Allison Stephans, Leggy A. Arnold, N'Guessan D.-R. Diby, Elliot DiMilo, Vladyslava A. Snyder, Ricardo Rosas, Disha M. Gandhi, Teresa H.W. Yeung, Eric Greve, Kaitlin Kentala, Khia E. Kurtenbach
Publikováno v:
Bioorganicmedicinal chemistry. 27(17)
Novel analogs of the allosteric, biased PAR1 ligand ML161 (parmodulin 2, PM2) were prepared in order to identify potential anti-thrombotic and anti-inflammatory compounds of the parmodulin class with improved properties. Investigations of structure-a
Autor:
Disha Gandhi, Ricardo Rosas, Jr., Eric Greve, Kaitlin Kentala, N'Guessan Diby, Vladyslava Snyder, Allison Stephans, Teresa Yeung, Saravanan Subramaniam, Khia Kurtenbach, Elliot DiMilo, Leggy Arnold, Hartmut Weiler, Chris Dockendorff
Novel analogs of the allosteric, biased PAR1 ligand ML161 (parmodulin 2, PM2) were prepared in order to identify potential anti-thrombotic and anti-inflammatory compounds of the parmodulin class with improved properties. Investigations of structure-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4105f5773805e9ed4e20bd6520779595
https://doi.org/10.26434/chemrxiv.7755479.v1
https://doi.org/10.26434/chemrxiv.7755479.v1